FDA Inspection
Preferred Pharmaceuticals, Inc.Preferred Pharmaceuticals, Inc. – FDA Inspection, Jan 14, 2020
Record Details
This FDA Inspection record concerns Preferred Pharmaceuticals, Inc., with an inspection on January 14, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 14, 2020
- Product Type
- Drugs
View Company Profile
ID · 4f48a4f2-359c-4d07-8ff7-52c96ddf3c91
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1115035
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.110(a)Written in-process control procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Preferred Pharmaceuticals, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 27, 2025 | VAI | Los Angeles District Office | Drug Quality Assurance |
| January 29, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 29, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 17, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 30, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Preferred Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.